
Opinion|Videos|November 5, 2024
Integrating VMS Treatment Into Comprehensive Women’s Health Management
Key Takeaways
- Hormone therapy for VMS requires careful evaluation of risks, especially in women with pre-existing conditions.
- Non-hormonal treatments and lifestyle modifications are vital in managing menopause-related symptoms.
Panelists discuss how to effectively integrate vasomotor symptom (VMS) treatment into comprehensive health management plans for women, taking into account the significant comorbidities associated with menopause, such as cardiovascular disease and osteoporosis.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- (FIFFICK) Considering the significant comorbidities often associated with menopause, such as cardiovascular disease and osteoporosis, how should VMS treatment be integrated into a broader health management plan for women?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Sotatercept Indication for PAH
2
Patients, Providers Strongly Favor Oral Therapies in Psoriasis
3
Proactive MG Management Hinges on Better Coverage and Guidelines
4
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
5











































